$0 Co-pay per dose or per
one-month supply for oral
medications*
The BMS Access Support Co-Pay Assistance Program
helps eligible, commercially insured patients who have been prescribed select BMS medications with out-of-pocket deductibles, co-pays, or co-insurance requirements.
*Subject to a maximum benefit. Restrictions apply. For full terms and conditions, including complete eligibility requirements, please click here for oral products, here for HCP-administered products, and here for NULOJIX (belatacept).
To get started,
please select a medication.
.svg)
U.S. Full Prescribing Information for ABRAXANE, including Boxed WARNING
U.S. Full Prescribing Information for IDHIFA,
including Boxed WARNING
U.S. Full Prescribing Information for INREBIC,
including Boxed WARNING
U.S. Full Prescribing Information for POMALYST,
including Boxed WARNING
U.S. Full Prescribing Information for REVLIMID,
including Boxed WARNING
U.S. Full Prescribing Information for THALOMID, including Boxed WARNING
U.S. Full Prescribing Information for NULOJIX, including Boxed WARNING